Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.
综合筛查发现 GPR31 是代谢功能障碍相关脂肪性肝炎的关键驱动因素和可药物靶点
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI173193
Zhang Xiao-Jing, Fu Jiajun, Cheng Xu, Shen Hong, Yang Hailong, Wang Kun, Li Wei, Tian Han, Tian Tian, Zhou Junjie, Tian Song, Wang Zhouxiang, Wan Juan, Bai Lan, Duan Hongfei, Zhang Xin, Tian Ruifeng, Xu Haibo, Liao Rufang, Zou Toujun, Shi Jing, Qu Weiyi, Fang Liang, Cai Jingjing, Zhang Peng, She Zhi-Gang, Jiang Jingwei, Hu Yufeng, Wang Yibin, Li Hongliang
